Rhabdomyolysis associated with antimicrobial drug-resistant Mycoplasma pneumoniae

Emerg Infect Dis. 2012 May;18(5):849-51. doi: 10.3201/eid1805.111149.

Abstract

We describe a case of rhabdomyolysis in a patient infected with antimicrobial drug-resistant Mycoplasma pneumoniae The patient's acute-phase serum levels of interleukin-18 and tumor necrosis factor-α were high, which suggests a pathogenic role for M. pneumoniae. In an era of increasing antimicrobial drug resistance, a system for rapidly identifying resistant M. pneumoniae would be beneficial.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Drug Resistance, Bacterial* / genetics
  • Female
  • Humans
  • Mutation
  • Mycoplasma pneumoniae / drug effects
  • Mycoplasma pneumoniae / genetics
  • Pneumonia, Mycoplasma / complications*
  • Pneumonia, Mycoplasma / diagnosis
  • Pneumonia, Mycoplasma / drug therapy
  • RNA, Ribosomal, 23S / genetics
  • Rhabdomyolysis / diagnosis*
  • Rhabdomyolysis / microbiology*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 23S